zydus cadila

Cadila jab immunogenic, safe, Phase 1 trial data suggests

According to a 48-person phase I study published ahead of print in the Lancet’s EClinicalMedicine journal, the DNA vaccine produced by Indian pharmaceutical company Zydus Cadila was shown to be safe and... Read more »
usfda

Zydus Cadila gets tentative nod from USFDA to market cancer drug

New Delhi: Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used in the treatment of certain types of cancers. The company has received... Read more »
zydus cadila

Zydus’ Covid vaccine for kids above 12 may come up this week

The drug regulatory body of India will consider emergency use approval for Zydus Cadila’s Covid-19 vaccine this week and the Subject Expert Committee (SEC) will examine the data submitted by the company.... Read more »
zydus cadila

Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets

Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic Emtricitabine and Tenofovir Disoproxil Fumarate tablets used for treatment of HIV infection. The company has received... Read more »
zydus cadila

Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets

Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic Emtricitabine and Tenofovir Disoproxil Fumarate tablets used for treatment of HIV infection. The... Read more »
zydus cadila

Zydus Cadila applies for emergency use nod for COVID-19 vaccine

Zydus Cadila has approached India’s top drug regulator for restricted emergency approval of ZyCov-D, its three-dose Covid-19 vaccine. If granted, this would be the first DNA vaccine available in the world. The company, which... Read more »
zydus cadila

3-dose Zydus Cadila likely to seek emergency nod for ZyCoV-D in a week: Report

Zydus Cadila, the Ahmedabad-based vaccine maker, is likely to apply for emergency use authorisation to the Drug Controller General of India in a week, news agency ANI reported. In that case, it... Read more »
zydus cadila

Zydus Cadila gets tentative US FDA approval for Brivaracetam tablets

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg (US RLD: Briviact Tablets).... Read more »
zydus cadila

Zydus granted permission for clinical trials of antibody cocktails

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission to conduct clinical trials by the Subject Expert Committee (SEC) of Central... Read more »
zydus cadila

USFDA nod to Zydus for production of Fluphenazine Hydrochloride

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets). This... Read more »